Background
Situation of FSW in Germany
Prevalence of STI in FSW
Methods
Setting and study population
Data collection
Basic survey
Monthly questionnaire
Case definitions
Data analysis
Data protection issues
Results
Description of study sites
LPHD characteristics | West incl. Berlin | East | Total | |
---|---|---|---|---|
Population size covered | <250,000 | 10 | 4 | 14 |
250,000- < 500,000 | 4 | 0 | 4 | |
≥500,000 | 8 | 2 | 10 | |
Monthly number of attendees | 1–25 | 8 | 1 | 9 |
26–50 | 1 | 2 | 3 | |
51–100 | 5 | 2 | 7 | |
>100 | 7 | 1 | 8 | |
Missing | 1 | 0 | 1 | |
Proportion of FSW among attendees | 1–25% | 10 | 4 | 14 |
26–50% | 3 | 0 | 3 | |
51–75% | 2 | 0 | 2 | |
76–100% | 6 | 2 | 8 | |
Missing | 1 | 0 | 1 | |
Number of STI tests offereda | Only HIV-test | 1 | 0 | 1 |
HIV plus 2–6 STI tests | 5 | 1 | 6 | |
HIV plus 7 STI tests | 16 | 5 | 21 |
FSW visits
STI tests performed
Tests | Number of LPHD offering test (%) | Number of performed tests | Median number tests per LPHDa | Median proportion of tests per FSW visit in % (IQR)a | Number of FSW visits with positive test | Proportion of positive tests in % (IQR)a |
---|---|---|---|---|---|---|
HIV | 28 (100) | 3882 | 86.5 | 66.0 (47.9–86.8) | 8 | 0.2 (0.0–0.4) |
Chlamydia trachomatis
| 27 (96) | 5353 | 94.5 | 65.4 (50.7–83.6) | 366 | 6.8 (2.5–10.4) |
Neisseria gonorrhoea
| 26 (93) | 6005 | 143.5 | 77.1 (60.7–88.0) | 195 | 3.2 (0.0–5.3) |
Syphilis | 27 (96) | 4474 | 135.0 | 61.6 (48.6–78.6) | 50 | 1.1 (0.0–1.3) |
Trichomonas vaginalis
| 18 (64) | 3200 | 67.0 | 45.2 (14.2–71.6) | 97 | 3.0 (0.0–15.4) |